RxDoctor Payments Data

Douglas Raedy, DO

Otolaryngology · Portage, MINPI 1215111885

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Intersect ENT, Inc. at 40.1% of the total. Reporting peaked in 2021 at $1,404 and has fallen 68.8% since, to $438 in 2025.

$4,967in general payments, 2019–2025

Across 142 payments — averaging $34.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$2K
  • Acclarent, Inc$635
  • Aerin Medical Inc.$421
  • Optinose US, Inc.$372
  • Stryker$365
  • Sanofi$245
  • plus $937 from 19 others

What the payments were for

  • Food & beverage$4,967100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,967 in reported general payments places this provider in the 80th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$77,780
Medicare patients
211
Services billed
1,055

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocortisone-Acetic AcidHydrocortisone/Acetic Acid51$6,720
Ipratropium Bromide177$4,125
Rabeprazole Sodium103$3,302
Tobramycin-DexamethasoneTobramycin/Dexamethasone17$2,310
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth19$1,826
Doxycycline Hyclate75$565
Ofloxacin16$560
Triamcinolone Acetonide19$437
Methylprednisolone65$434
Mupirocin51$404
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen57$258
Fluticasone Propionate15$233
Levocetirizine Dihydrochloride12$131
Chlorhexidine Gluconate32$115
Levofloxacin20$100

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Portage

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →